Trial of Oral Melatonin in Elevated Blood Pressure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

Also called NCT03764020

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03764020
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03764020. Randomized; triple masking; primary purpose treatment. Start 2019-06-01 (anticipated); primary completion 2019-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial of Oral Melatonin in Elevated Blood Pressure
Acronym
MRCTEBP
Condition
Elevated Blood Pressure
Intervention (Drug)
Placebo oral capsule/placebo comparator
Intervention (Drug)
Melatonin/experimental
Lead sponsor
Tehran University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct03764020
Content hash
753ae7cd8258a8b131b100af2fb5d24c53fd1ec8be769823862b620363a85265